Turn Therapeutics Inc. (TTRX)

♥ 561 Thanks from members

Turn Therapeutics Inc. (TTRX) faces a delicate balance between promising clinical data for its lead topical immunomodulator GX-03 in eczema and severe financial headwinds, flagged by a growing net loss and a going concern warning.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ

Microchip Technology Incorporated (MCHP)

NASDAQ

Direxion Daily AAPL Bear 1X ETF (AAPD)

NASDAQ

Ascentage Pharma Group International - American Depository Shares (AAPG)

NASDAQ

Direxion Daily AAPL Bull 2X ETF (AAPU)

NASDAQ

Alpha Blue Capital US Small-Mid Cap Dynamic ETF (ABCS)

NASDAQ

AbCellera Biologics Inc. - Common Shares (ABCL)

Entity & Market Metadata

Sector: Healthcare Industry: Biotechnology Founder: Turn Therapeutics Team Leadership: Bradley Burnam (CEO) Holder: Private Investors Holder: Insiders Wound Care Formulations Dermatology Treatments Antimicrobial Gels #Turn Therapeutics #TTRX #wound care biotech #dermatology therapeutics #NASDAQ TTRX